(Q35603887)

9 August 2017

1 reference

title

Metronomic therapy for breast cancer (English)

1 reference

9 August 2017

Hanspreet Kaur

1

1 reference

PubMed ID

14664761

9 August 2017

G Thomas Budd

series ordinal

2

1 reference

9 August 2017

1 January 2004

1 reference

9 August 2017

Current Oncology Reports

1 reference

9 August 2017

6

1 reference

9 August 2017

1

1 reference

9 August 2017

49-52

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-996-0009-5

9 August 2017

0 references

cites work

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-996-0009-5

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-996-0009-5

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

21 January 2018

1 reference

12 December 2020

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

12 December 2020

Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines.

1 reference

12 December 2020

Cancer: looking outside the genome

1 reference

12 December 2020

Dose-dense anthracycline-based chemotherapy for node-positive breast cancer

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer

1 reference

12 December 2020

Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts

1 reference

12 December 2020

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

12 December 2020

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

1 reference

12 December 2020

"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)

1 reference

12 December 2020

Redefining the target: chemotherapeutics as antiangiogenics

1 reference

12 December 2020

Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.

1 reference

12 December 2020

Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.

1 reference

12 December 2020

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

1 reference

12 December 2020

Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.

1 reference

12 December 2020

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

1 reference

12 December 2020

Docetaxel administered on a weekly basis for metastatic breast cancer

1 reference

12 December 2020

Antiangiogenic scheduling of lower dose cancer chemotherapy.

1 reference

12 December 2020

The onset and extent of genomic instability in sporadic colorectal tumor progression

1 reference

12 December 2020

10.1007/S11912-996-0009-5

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14664761